Our CEO, Emily Taylor, is featured in LA Weekly for her leadership in shaping the Solve ME/CFS Catalyst Awards—an innovative program that supports critical ME/CFS and Long Covid research.
The article highlights how these awards drive progress, support promising studies, and amplify the voices of patients in steering scientific priorities. It also covers how her lived experience as a caregiver informs her work at Solve, including the development of the Catalyst Awards program.
Emily told LA Weekly, “Caring for my mother with ME/CFS helped me see where medicine, support, and policy can grow stronger. ME/CFS is a condition marked by profound fatigue, pain, post-exertional malaise, and a range of neurological and systemic symptoms. Living alongside those realities showed me how important it is to design systems that truly meet people’s needs.”
Dive into the story to see how Taylor’s vision and commitment are accelerating breakthroughs that could change the future for millions affected by these complex conditions.
Read the LA Weekly story here.
Just this week, we announced the latest round of Catalyst Award winners. Read more about the award-winning studies from Dr. Jay H. Chung and the DecodeME Management Team here.